J. Levine

发表

Open-Heart Surgery in a Patient with Heterozygous α2-Antiplasmin Deficiency: Perioperative Strategies in the First Reported Case

D. Shahian, J. Levine, 1990 .

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

D. Neuberg, D. Kufe, D. DeAngelo, 2016, Science Translational Medicine.

Primary Large Cell Neuroendocrine Carcinoma of the Breast, a Case Report with an Unusual Clinical Course

L. Moy, S. Adams, J. Cangiarella, 2015, The breast journal.

Yttrium-90 Ibritumomab Tiuxetan Followed by Rituximab Maintenance as Treatment for Patients with Diffuse Large B-Cell Lymphoma Are Not Candidates for Autologous Stem Cell Transplant

J. Zwicker, R. Joyce, J. Levine, 2015, Acta Haematologica.

Tumor and Stem Cell Biology MUC 1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

L. Yin, Keisuke Ito, D. Kufe, 2013 .

Generation of human T lymphocytes from bone marrow CD34+ cells in vitro

S. Kalams, D. Scadden, A. Freedman, 1996, Nature Medicine.

Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.

R. Soiffer, R. Joyce, Shuli Li, 2016, Blood.

Vaccination with DC/tumor fusion cells results in cellular and humoral anti-tumor immune responses in patients with multiple myeloma DC/myeloma fusion vaccine induces immune responses

N. Munshi, P. Richardson, D. Kufe, 2017 .

A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).

M. Regan, D. McDermott, R. Joyce, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunomodulatory effects of vitamin D: implications for GVHD

D. Kufe, R. Ahmad, V. Boussiotis, 2010, Bone Marrow Transplantation.

In vivo effects of interleukin 3 in HIV type 1-infected patients with cytopenia.

S. Hammer, D. Scadden, D. Resta, 1995, AIDS research and human retroviruses.

Title: Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

N. Munshi, J. Laubach, P. Richardson, 2013 .

Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.

P. Richardson, D. Kufe, R. Joyce, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lenalidomide enhances anti-myeloma cellular immunity

D. Kufe, J. Zwicker, R. Joyce, 2012, Cancer Immunology, Immunotherapy.

Sequential infusion of donor‐derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation

J. Ritz, R. Soiffer, R. Joyce, 2014, American journal of hematology.

Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma.

D. Scadden, J. Groopman, J. Levine, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

P. Richardson, D. Kufe, D. McDermott, 2000, Bone Marrow Transplantation.

Recombinant human erythropoietin for patients with AIDS treated with zidovudine.

M. Fischl, J. Groopman, S. Rudnick, 1990, The New England journal of medicine.

Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab

A. Atsawarungruangkit, J. Levine, M. Mahoney, 2018, Leukemia & lymphoma.

Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Nikhil C. Munshi, Edie Weller, Kenneth Anderson, 2013, Clinical Cancer Research.

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

N. Munshi, P. Richardson, D. Kufe, 2011, Blood.

PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine

D. Kufe, R. Joyce, J. Levine, 2011, Journal of immunotherapy.

Functional isolation and characterization of human hematopoietic stem cells.

D. Scadden, A. Berardi, J. Levine, 1995, Science.

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J. Ritz, P. Westervelt, J. Dipersio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer

G. Demetri, P. Richardson, R. Joyce, 2001, Bone Marrow Transplantation.

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

D. Neuberg, D. Zahrieh, K. Ballen, 2008, Clinical Cancer Research.

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia.

P. Pandolfi, D. Kufe, R. Joyce, 2017, Blood.

DC/Aml Fusion Cell Vaccination Administered to AML Patients Who Achieve a Complete Remission Potently Expands Leukemia Reactive T Cells and Is Associated with Durable Remissions

D. Neuberg, D. Kufe, D. DeAngelo, 2015 .

Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients

D. Neuberg, D. Kufe, D. DeAngelo, 2013 .

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.

P. Pandolfi, L. Yin, Keisuke Ito, 2013, Cancer research.

Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28

D. Neuberg, D. Kufe, K. Stevenson, 2010, Journal of immunotherapy.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies

P. Richardson, D. McDermott, R. Joyce, 2001, Bone Marrow Transplantation.

Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

N. Munshi, J. Laubach, P. Richardson, 2012 .

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

J. Ritz, P. Westervelt, J. Dipersio, 2016 .

Rituximab and ifosfamide, mitoxantrone, etoposide (RIME) with Neupogen support for B-cell non-Hodgkin's lymphoma prior to high-dose chemotherapy with autologous haematopoietic transplant.

M. Regan, D. McDermott, R. Joyce, 2001, European journal of haematology. Supplementum.

MUC 1 IS A POTENTIAL TARGET FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA STEM CELLS

Caterina, Rajabi, P. Pandolfi, 2014 .

Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia

D. Neuberg, D. Zahrieh, K. Ballen, 2008, Clinical Cancer Research.

GM‐CSF as an Alternative to Dose Modification of the Combination Zidovudine and Interferon-α in the Treatment of AIDS‐Associated Kaposi's Sarcoma

D. Scadden, J. Groopman, J. Levine, 1991, American journal of clinical oncology.